dose of aspirin
Last edited 05/2021 and last reviewed 06/2021
- the minimum effective dose for aspirin, taken from evidence from secondary prevention studies, is in the order of 75 mg per day for patients at risk of arteriothrombotic events and 160 mg/day for the treatment of acute myocardial infarction (1)
- a systematic review concluded that "..currently available clinical data do not support the routine, long-term use of aspirin dosages greater than 75 to 81 mg/d in the setting of cardiovascular disease prevention. Higher dosages, which may be commonly prescribed, do not better prevent events but are associated with increased risks of gastrointestinal bleeding..." (2)
- dose of aspirin in the prevention of cardiovascular disease:
- an open-label pragmatic trial found no differences in cardiovascular events (event rate 7.28% vs 7.51%; HR 1.02; 95% CI 0.91 to 1.14) or major bleeding (0.63% vs 0.60%; HR 1.18; 95% CI, 0.79 to 1.77) in patients with CVD assigned to 81 mg or 325 mg of aspirin daily, respectively (3)
- there was substantial dose switching to 81 mg of daily aspirin and no significant differences in cardiovascular events or major bleeding between patients assigned to 81 mg and those assigned to 325 mg of aspirin daily
- an open-label pragmatic trial found no differences in cardiovascular events (event rate 7.28% vs 7.51%; HR 1.02; 95% CI 0.91 to 1.14) or major bleeding (0.63% vs 0.60%; HR 1.18; 95% CI, 0.79 to 1.77) in patients with CVD assigned to 81 mg or 325 mg of aspirin daily, respectively (3)
Reference:
- (1) Patrono C et al. Platelet-active drugs: the relationships among dose, effectiveness and side effects. Chest 2001;199:395-635.
- (2) Campbell CL et al. Aspirin dose for the prevention of cardiovascular disease: a systematic review.JAMA. 2007 May 9;297(18):2018-24
- (3) Jones WS et al. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.May 15, 2021 DOI: 10.1056/NEJMoa2102137